S3I-201 (NSC 74859, Figure 3k) is a selective chemical probe inhibitor of STAT3 and binds to the STAT3 phosphotyrosine peptide (PY*LKT) with the potential to become a radiosensitizer for esophageal cancer radiotherapy [88,211]. Here, STAT3 is linked to esophageal cancer.